Literature DB >> 20687106

Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas.

Lijun Heng1, Joel A Beverley, Heinz Steiner, Kuei Y Tseng.   

Abstract

Cannabis use during adolescence is associated with an increased risk for schizophrenia and other disorders. The neuronal basis is unclear, but prefrontal cortical mechanisms have been implicated. Here, we investigated developmental changes in the endocannabinoid system by assessing expression and function of the CB1 cannabinoid receptor in prefrontal and other cortical areas in juvenile (postnatal day 25, P25), adolescent (P40), and adult (P70) rats. Overall, the expression of CB1 receptors in the cortex is highest in juveniles and drops thereafter toward adult levels. However, CB1 receptor expression follows distinct developmental trajectories in different cortical areas. The most pronounced and progressive decrease in CB1 expression was observed in medial prefrontal and other limbic/associative regions. In contrast, major changes in sensorimotor cortices occurred only after P40. We also assessed electrophysiological measures of CB1 receptor function and found that CB1-dependent inhibition of synaptic transmission in the prefrontal cortex follows the same developmental trajectory as observed for receptor expression. Together, these findings indicate that CB1 receptor-mediated signaling decreases during development but is differentially regulated in limbic/associative vs. sensorimotor systems. Therefore, cannabis use during adolescence likely differentially affects limbic/associative and sensorimotor cortical circuits.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20687106      PMCID: PMC2978763          DOI: 10.1002/syn.20844

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  39 in total

Review 1.  Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia.

Authors:  Christos Pantelis; Murat Yücel; Stephen J Wood; Dennis Velakoulis; Daqiang Sun; Gregor Berger; Geoff W Stuart; Alison Yung; Lisa Phillips; Patrick D McGorry
Journal:  Schizophr Bull       Date:  2005-07-14       Impact factor: 9.306

2.  The environment and schizophrenia: the role of cannabis use.

Authors:  Cécile Henquet; Robin Murray; Don Linszen; Jim van Os
Journal:  Schizophr Bull       Date:  2005-06-23       Impact factor: 9.306

Review 3.  The emerging functions of endocannabinoid signaling during CNS development.

Authors:  Tibor Harkany; Manuel Guzmán; Ismael Galve-Roperh; Paul Berghuis; Lakshmi A Devi; Ken Mackie
Journal:  Trends Pharmacol Sci       Date:  2007-01-10       Impact factor: 14.819

Review 4.  Neurodevelopmental changes in working memory and cognitive control.

Authors:  Silvia A Bunge; Samantha B Wright
Journal:  Curr Opin Neurobiol       Date:  2007-02-23       Impact factor: 6.627

Review 5.  Presynaptic modulation by endocannabinoids.

Authors:  David M Lovinger
Journal:  Handb Exp Pharmacol       Date:  2008

6.  Hardwiring the brain: endocannabinoids shape neuronal connectivity.

Authors:  Paul Berghuis; Ann M Rajnicek; Yury M Morozov; Ruth A Ross; Jan Mulder; Gabriella M Urbán; Krisztina Monory; Giovanni Marsicano; Michela Matteoli; Alison Canty; Andrew J Irving; István Katona; Yuchio Yanagawa; Pasko Rakic; Beat Lutz; Ken Mackie; Tibor Harkany
Journal:  Science       Date:  2007-05-25       Impact factor: 47.728

7.  Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning.

Authors:  Jan Mulder; Tania Aguado; Erik Keimpema; Klaudia Barabás; Carlos J Ballester Rosado; Laurent Nguyen; Krisztina Monory; Giovanni Marsicano; Vincenzo Di Marzo; Yasmin L Hurd; Francois Guillemot; Ken Mackie; Beat Lutz; Manuel Guzmán; Hui-Chen Lu; Ismael Galve-Roperh; Tibor Harkany
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

8.  Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.

Authors:  M Ellgren; A Artmann; O Tkalych; A Gupta; H S Hansen; S H Hansen; L A Devi; Y L Hurd
Journal:  Eur Neuropsychopharmacol       Date:  2008-11       Impact factor: 4.600

Review 9.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

10.  Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons.

Authors:  Dale A Fortin; Eric S Levine
Journal:  Cereb Cortex       Date:  2006-02-08       Impact factor: 5.357

View more
  61 in total

1.  Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice.

Authors:  Abigail E Agoglia; Sarah E Holstein; Vallari R Eastman; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2016-01-19       Impact factor: 3.533

Review 2.  Neural substrates underlying the negative impact of cannabinoid exposure during adolescence.

Authors:  Hanna M Molla; Kuei Y Tseng
Journal:  Pharmacol Biochem Behav       Date:  2020-06-09       Impact factor: 3.533

3.  Altered dendritic distribution of dopamine D2 receptors and reduction in mitochondrial number in parvalbumin-containing interneurons in the medial prefrontal cortex of cannabinoid-1 (CB1) receptor knockout mice.

Authors:  Megan L Fitzgerald; June Chan; Kenneth Mackie; Carl R Lupica; Virginia M Pickel
Journal:  J Comp Neurol       Date:  2012-12-01       Impact factor: 3.215

4.  Adolescent cannabinoid exposure permanently suppresses cortical oscillations in adult mice.

Authors:  Sylvina M Raver; Sarah P Haughwout; Asaf Keller
Journal:  Neuropsychopharmacology       Date:  2013-07-04       Impact factor: 7.853

Review 5.  Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects.

Authors:  Yasmin L Hurd; Olivier J Manzoni; Mikhail V Pletnikov; Francis S Lee; Sagnik Bhattacharyya; Miriam Melis
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

Review 6.  Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System.

Authors:  Shana M Augustin; David M Lovinger
Journal:  ACS Chem Neurosci       Date:  2018-02-19       Impact factor: 4.418

7.  Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia.

Authors:  Felipe V Gomes; Jessica R Edelson; David W Volk; Anthony A Grace
Journal:  Schizophr Res       Date:  2018-04-26       Impact factor: 4.939

8.  Δ9-Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult.

Authors:  Emma Leishman; Michelle Murphy; Ken Mackie; Heather B Bradshaw
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-02-08       Impact factor: 4.698

9.  Short-Term Genetic Selection for Adolescent Locomotor Sensitivity to Delta9-Tetrahydrocannabinol (THC).

Authors:  Chelsea R Kasten; Yanping Zhang; Ken Mackie; Stephen L Boehm
Journal:  Behav Genet       Date:  2018-03-17       Impact factor: 2.805

10.  Late adolescent expression of GluN2B transmission in the prefrontal cortex is input-specific and requires postsynaptic protein kinase A and D1 dopamine receptor signaling.

Authors:  Eden Flores-Barrera; Daniel R Thomases; Li-Jun Heng; Daryn K Cass; Adriana Caballero; Kuei Y Tseng
Journal:  Biol Psychiatry       Date:  2013-09-13       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.